SE0202311D0 - Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment - Google Patents
Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatmentInfo
- Publication number
- SE0202311D0 SE0202311D0 SE0202311A SE0202311A SE0202311D0 SE 0202311 D0 SE0202311 D0 SE 0202311D0 SE 0202311 A SE0202311 A SE 0202311A SE 0202311 A SE0202311 A SE 0202311A SE 0202311 D0 SE0202311 D0 SE 0202311D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- retinoyl
- acid
- methods
- preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
- C07C309/18—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton containing amino groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/04—Sulfinic acids; Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202311A SE0202311D0 (sv) | 2002-07-23 | 2002-07-23 | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment |
PCT/SE2002/002087 WO2004009538A1 (en) | 2002-07-23 | 2002-11-15 | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
AU2002347747A AU2002347747A1 (en) | 2002-07-23 | 2002-11-15 | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
US10/295,139 US7030158B2 (en) | 2002-07-23 | 2002-11-15 | Therapeutic compounds |
CNB028296087A CN100360502C (zh) | 2002-07-23 | 2002-11-15 | 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用 |
ES02783947.1T ES2452540T3 (es) | 2002-07-23 | 2002-11-15 | Derivados de retinol, su uso en el tratamiento del cáncer y para potenciar la eficacia de otros agentes citotóxicos |
PT27839471T PT1534672E (pt) | 2002-07-23 | 2002-11-15 | Derivados de retinol, a sua utilização no tratamento do cancro e para potenciar a eficácia de outros agentes citotóxicos |
DK02783947.1T DK1534672T3 (da) | 2002-07-23 | 2002-11-15 | Retinolderivater, deres anvendelse til behandling af cancer og til potensering af virkningen af andre cytotoksi¬ske midler |
EP02783947.1A EP1534672B1 (en) | 2002-07-23 | 2002-11-15 | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
HK06100168.0A HK1080447B (zh) | 2002-07-23 | 2006-01-04 | 視黃醇衍生物、它們在治療癌症和增强其它細胞毒性劑功效中的應用 |
CY20131100567T CY1114788T1 (el) | 2002-07-23 | 2013-07-05 | Παραγωγα ρετινολης, χρηση αυτων στη θεραπεια καρκινου και για ενισχυση της αποτελεσματικοτητας αλλων κυτταροτοξικων παραγοντων |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202311A SE0202311D0 (sv) | 2002-07-23 | 2002-07-23 | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0202311D0 true SE0202311D0 (sv) | 2002-07-23 |
Family
ID=20288630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0202311A SE0202311D0 (sv) | 2002-07-23 | 2002-07-23 | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment |
Country Status (5)
Country | Link |
---|---|
US (1) | US7030158B2 (sv) |
DK (1) | DK1534672T3 (sv) |
ES (1) | ES2452540T3 (sv) |
PT (1) | PT1534672E (sv) |
SE (1) | SE0202311D0 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009078756A1 (en) * | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
WO2009078754A1 (en) * | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
WO2009078755A1 (en) * | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
EP3386947B1 (en) * | 2015-12-09 | 2021-05-19 | Oasmia Pharmaceutical AB | Method for producing n-retinoylaminoalkane sulfonic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4032187C2 (de) | 1990-10-10 | 1995-03-30 | Gradinger F Hermes Pharma | N-Retinoyl-L-aminomercapto-Verbindungen und Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung |
SE0101702D0 (sv) * | 2001-05-15 | 2001-05-15 | Ardenia Investments Ltd | Novel potentiating compounds |
-
2002
- 2002-07-23 SE SE0202311A patent/SE0202311D0/sv unknown
- 2002-11-15 PT PT27839471T patent/PT1534672E/pt unknown
- 2002-11-15 US US10/295,139 patent/US7030158B2/en not_active Expired - Lifetime
- 2002-11-15 ES ES02783947.1T patent/ES2452540T3/es not_active Expired - Lifetime
- 2002-11-15 DK DK02783947.1T patent/DK1534672T3/da active
Also Published As
Publication number | Publication date |
---|---|
US7030158B2 (en) | 2006-04-18 |
ES2452540T3 (es) | 2014-04-01 |
DK1534672T3 (da) | 2013-07-29 |
US20040048923A1 (en) | 2004-03-11 |
PT1534672E (pt) | 2013-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20075136L (no) | Nye liposompreparater | |
NZ591810A (en) | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid | |
UA108363C2 (uk) | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
EA201171376A1 (ru) | Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса | |
HRP20120803T1 (hr) | Prolijekovi alkilatora fosforamidata | |
UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
WO2005000232A3 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
EA201171088A1 (ru) | Лечение дискинезии при различных расстройствах | |
CY1112637T1 (el) | Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
SE0102440D0 (sv) | New compound | |
DE60233276D1 (de) | Verfahren zur Herstellung der Natrium Salze von Retinoylderivaten | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
SE0401655D0 (sv) | New compounds | |
NO20090067L (no) | Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer | |
DE60131416D1 (de) | Chirale fluorochinolizinon arginine salze | |
SE0202311D0 (sv) | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
BRPI0512151A (pt) | solução concentrada de sal de sódio monoidratado do tenatoprazol, composição farmacêutica, utilização do sal de sódio monoidratado do tenatoprazol, processo de preparação do sal de sódio monoidratado do tenatoprazol, e composição para administração por via oral do sal de sódio monoidratado do tenatoprazol | |
MX2023001572A (es) | Formas farmaceuticas sólidas de palbociclib. | |
DE60314920D1 (de) | Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat | |
MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. |